Science Pool

In Vitro Model at Centre of Antimicrobial Drug Development

The key to de-risking and expediting the development and approval of new antimicrobials is a detailed understanding of the PK/PD relationship. Our recent article on which discusses how the Hollow Fibre Infection Model can help mitigate the risk of clinical trial failure and extend the clinical utility of new antimicrobials.